(Q28297243)

9 April 2017

1 reference

Kirsty Le Doare

1

0 references

Paul Heath

object named as

Paul T Heath

series ordinal

2

0 references

Paul Heath

series ordinal

2

object named as

Paul T. Heath

1 reference

9 April 2017

language of work or name

English

0 references

publication date

28 August 2013

0 references

August 2013

1 reference

9 April 2017

1 reference

9 April 2017

volume

31 Suppl 4

0 references

31

1 reference

9 April 2017

page(s)

D7-12

0 references

D7-D12

1 reference

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.

9 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

FATAL INFECTIONS BY HqMOLYTIC STREPTOCOCCUS GROUP B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Beta hemolytic streptococcus group B associated with problems of the perinatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Suppurative meningitis due to streptococci of lancefield group B: A study of 33 infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B beta hemolytic streptococcal meningitis in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal meningitis: a review of routine national data 1975-83

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal group B streptococcal disease in Finland: a ten-year nationwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in Portuguese infants younger than 90 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal infections in infants. The importance of the various serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Characterization of group B streptococci recovered from infants with invasive disease in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Carriage of group B streptococcus in pregnant women from Oxford, UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Rapid detection of group B streptococci in pregnant women at delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in UK and Irish infants younger than 90 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Nosocomial transmission of group B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in infants: progress in prevention and continued challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Prematurity is the major risk factor for late-onset group B streptococcus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal systemic disease in Great Britain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Early onset group B streptococcal neonatal infection in Oxford 1985-96.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Meningitis in infancy in England and Wales: follow up at age 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Long-term outcomes of group B streptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Risk factors for early onset neonatal group B streptococcal sepsis: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Premature rupture of the fetal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

7 January 2021

Group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Strategies for Chemoprophylaxis of GBS Early-Onset Infections1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in infants: a case control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Prospective studies of group B streptococcal infections in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Early-onset neonatal group B streptococcal septicaemia in siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Late-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Trends in sepsis-related neonatal mortality in the United States, 1985-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Missed opportunities for preventing group B streptococcus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Invasive group B streptococcal infection in infants, Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Bacteremia among children admitted to a rural hospital in Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal Group B Streptococcal bacteraemia in India: ten years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Maternal carriage of group B streptococci in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Variation in reported neonatal group B streptococcal disease incidence in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal bacteraemia in Wesley Guild Hospital, Ilesha, Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Etiology of serious infections in young Gambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal neonatal infections in Rio Grande do Sul, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal Septicaemia at the Jordan University Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Six year trend of neonatal septicaemia in a large Malaysian maternity hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Neonatal Sepsis in Pakistan: Presentation and Pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Pathogens associated with sepsis in newborns and young infants in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Acute deaths in nonpregnant adults due to invasive streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Risk factors for group B streptococcal disease in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcus bacteremia in nonpregnant adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Invasive group B streptococcal disease: the emergence of serotype V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Group B streptococcal disease in nonpregnant adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009

Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.009